	Plasma PFDN2 suppresses head and neck squamous cell carcinoma progression by restricting CD64 on monocyte-driven inflammatory microenvironments. Front Immunol Feng C, Li C, Lei D. PMID: 41884853 [PubMed - indexed for MEDLINE]
	Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study. Drug Des Devel Ther Zhang S, Su C, Shen ZB, Huo J, Yang JP. PMID: 41884476 [PubMed - indexed for MEDLINE]
	Emerging Salivary Exosome Nanodiagnostics for Early Oral Squamous Cell Carcinoma: Platforms, Biomarkers, and Future Perspectives. Int J Nanomedicine Zhao LX, Wang ET, Jia WH, Wang MH, Pan Z, Dong L, Wen HQ, Xu WH, Xu R. PMID: 41884281 [PubMed - indexed for MEDLINE]
	Melanoma leptomeningeal disease: Advances in diagnosis and emerging therapeutic strategies. World J Exp Med Middleton ML, Lucke-Wold B. PMID: 41883443 [PubMed]
	Prognostic value of preoperative coagulation scoring system in patients with oral squamous cell carcinoma. Braz Oral Res Wang X, Ji X. PMID: 41880446 [PubMed - indexed for MEDLINE]
	Prospective Evidence on Artificial Intelligence-Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis. JAMA Dermatol Laiouar-Pedari S, Kühn A, Wies C, Garcia CN, Winterstein JT, Heinlein L, Hoffsommer A, Chanda T, Haggenmüller S, Brinker TJ. PMID: 41879756 [PubMed - as supplied by publisher]
	Predicting complete response to concurrent chemoradiotherapy in locally advanced cervical squamous cell carcinoma using multi-sequence MRI data and a 2.5D deep learning algorithm integrated with crossformer model. Sci Prog Chen C, Guo L, Li S, Sun J, Pei L, Ren W. PMID: 41877370 [PubMed - indexed for MEDLINE]
	Characterizing Treatment Delays in Patients With HPV-Negative Oropharyngeal Cancer. Cancer Med Pauley A, Fereira SJ, Pham TB, Vo V, Guidry H, Ramsey C, Guo T. PMID: 41876381 [PubMed - indexed for MEDLINE]
	Clinical characteristics, treatment options, and prognosis of subcutaneous panniculitis-like T-cell lymphoma from the SEER database. Hematology Zhang L, Chen Z, Lu L, Xiang B. PMID: 41876379 [PubMed - indexed for MEDLINE]
	Engineering organic, inorganic, carbon, and hybrid materials for skin cancer theragnostic: a focus on melanoma and non-melanoma. Mikrochim Acta Murugan P, Singaravel V, Manikandan C, Praburaman L, Moovendhan M, Dharmalingam K, Liu SY. PMID: 41874729 [PubMed - in process]
	Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV). Cancer Immunol Immunother Mollica V, Massari F, Fujita K, Giannatempo P, Grande E, Büttner T, Bourlon MT, Taha T, Fukuokaya W, Myint ZW, Pichler R, Binz K, Molina-Cerrillo J, Kopecky J, de Liaño AG, Kucharz J, Fiala O, Matrana MR, Kopp RM, Di Civita MA, Zgura A, Ansari J, Kihnel R, De Felice F, Angel M, Monteiro FSM, Soares A, Urun Y, Buti S, Santini D, Santoni M. PMID: 41874648 [PubMed - indexed for MEDLINE]
	Comparison between visual inspection, dermoscopy, and reflectance confocal microscopy in the diagnosis of lentigo maligna - a systematic review. Eur J Dermatol Fanton Gallo B, Fogagnolo L, Ávila Ferreira L, Cintra ML, Ingrid Amstalden EM. PMID: 41872078 [PubMed - indexed for MEDLINE]
	Sentinel Lymph Node Biopsy for Desmoplastic Melanoma: A Systematic Review and Meta-analysis. Ann Surg Oncol Yee P, Shen C, Jeun C, Mayhew M, Witt RG. PMID: 41870859 [PubMed - as supplied by publisher]
	Increased Risk of Melanoma and Basal Cell Carcinoma in Patients with Sjogren's Syndrome: A Nested Case-Control Study. Arch Dermatol Res Vaidyula VR, Lambert R, Alani O, Ungar B, Gulati N, Adalsteinsson JA. PMID: 41867668 [PubMed]
	Peripheral Blood Neutrophils and Monocytes Predict Disease Progression in Stage III Melanoma Patients Treated With Anti Programmed Cell Death Protein-1 (PD-1) Inhibitors. J Immunol Res Ventrici A, Modestino L, Cristinziano L, Caraglia F, Spatocco I, Tocchetti CG, Troiani T, Poto R, de Candia P, Varricchi G, Galdiero MR. PMID: 41866888 [PubMed - indexed for MEDLINE]
	Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy. Cancer Med Llerena P, Kaki PC, Nunes K, Mastrolonardo E, Bridgham K, Moroco AE, Samarah H, Barbirou M, Baek D, Wang C, Ad VB, Cognetti DM, Curry JM, Johnson JM, Yang H, Harshyne LA, Luginbuhl AJ. PMID: 41866628 [PubMed - indexed for MEDLINE]
	Younger Age at Melanoma Diagnosis: A Survey Study of Indoor Tanning Use. J Am Acad Dermatol Mahoney M, Wu A, Li H, Guo D, Burbidge T, Batuyong E, Poleman S, Ernst M, Cheng T. PMID: 41864291 [PubMed - as supplied by publisher]
	Correction to: Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma: a nationwide population-based registry study from Sweden. Br J Dermatol PMID: 41863261 [PubMed - as supplied by publisher]
	Development of Glioblastoma Multiforme in Patients With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma: A Case Series. Cancer Rep (Hoboken) Lovett JT, Wotman M, Denu R, Mandava A, Shah H, Sebra R, Westra W, Posner M. PMID: 41863061 [PubMed - indexed for MEDLINE]
	The cost-effectiveness of tumour-infiltrating lymphocyte cell therapy for advanced melanoma: a systematic review. BMC Cancer Wu M, Larkin J, Furness A, Stavropoulou C. PMID: 41862835 [PubMed - as supplied by publisher]

Articles 1 - 20 / 142070

Page 1 of 7104



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy